Orphazyme A/S Company Overview, Contact Details & Competitors

Insights

Gathering insights about Orphazyme A/S…

Similar companies to Orphazyme A/S

Orphazyme A/S Tech Stack

Orphazyme A/S uses 8 technology products and services including jQuery Migrate, Underscore.js, Webpack, and more. Explore Orphazyme A/S's tech stack below.

jQuery Migrate
Javascript Libraries
Underscore.js
Javascript Libraries
Webpack
Miscellaneous
Ubuntu
Operating Systems
Amazon Web Services
Platform As A Service
PHP
Programming Languages
Yoast SEO
Search Engines
Twitter
Widgets

Media & News

Orphazyme Aps sold assets to Zevra Therapeutics Inc. in the amount of $12.8M on May 1st '22.
In May 2022, Zevra, then KemPharm, acquired arimoclomol, an orally-delivered, first-in-class investigational product candidate for the treatment of Niemann-Pick type C disease (“NPC”), from Orphazyme A/S as part of the Company’s long-term vision to evolve into a commercially-driven rare disease therapeutics company.
Feb 22, 2023 | www.biospace.com
Orphazyme Aps went public on Sep 1st '20.
In September 2020, Orphazyme completed its initial public offering (“IPO”), selling approximately 4 million American Depositary Shares (“ADSs” or “shares”) at $11.00 per share.
Dec 04, 2022 | www.gurufocus.com
Orphazyme Aps sells assets to KemPharm, Inc. in the amount of $12.8M.
Per the agreement, KemPharm will acquire all the assets and operations of Orphazyme for $12.8 million in cash.
May 17, 2022 | www.zacks.com
Orphazyme Aps partnered with KemPharm, Inc. on May 15th '22.
Orphazyme sees its deal with KemPharm as a way to satisfy its obligations to creditors as part of a court process.
May 16, 2022 | www.fiercebiotech.com
Christophe Bourdon left Orphazyme Aps as CEO on Jan 1st '22.
He will succeed Christophe Bourdon, who will resign from Orphazyme to take the role of CEO of LEO Pharma A/S, Orphazyme said.
Jan 31, 2022 | www.marketwatch.com
Orphazyme Aps hired Anders Vadsholt as CEO on Apr 1st '22.
Effective April 1, 2022, Chief Financial Officer (CFO), Anders Vadsholt, will be appointed CEO of Orphazyme.
Jan 31, 2022 | finance.yahoo.com
Orphazyme Aps launches update to financial outlook for 2021.
Orphazyme A/S (ORPHA.CO; ORPH or the “Company”), a late-stage biopharmaceutical company, today announces an update to its financial outlook for 2021 based on a review of preliminary unaudited financial results for the year ending December 31, 2021.
Jan 18, 2022 | finance.yahoo.com

Orphazyme A/S's Email Address Formats

Orphazyme A/S uses at least 1 format(s):

Orphazyme A/S Email Formats	Example	Percentage
First.Last@orphazyme.com	John.Doe@orphazyme.com	45%
Last@orphazyme.com	Doe@orphazyme.com	5%
First.Last@orphazyme.com	John.Doe@orphazyme.com	45%
Last@orphazyme.com	Doe@orphazyme.com	5%

Frequently Asked Questions

Where is Orphazyme A/S's headquarters located?

Orphazyme A/S's main headquarters is located at DK. The company has employees across 3 continents, including EuropeNorth AmericaAfrica.

What is Orphazyme A/S's phone number?

You can contact Orphazyme A/S's main corporate office by phone at

+45-70-70-2****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Orphazyme A/S's stock symbol?

Orphazyme A/S is a publicly traded company; the company's stock symbol is ORPHY.

What is Orphazyme A/S's official website and social media links?

Orphazyme A/S's official website is orphazyme.com and has social profiles on LinkedIn.

What is Orphazyme A/S's SIC code NAICS code?

Orphazyme A/S's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Orphazyme A/S have currently?

As of December 2021, Orphazyme A/S has approximately 108 employees across 3 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Commercial Officer And Us President: P. M.Head Of Global Product Strategy: A. H.Director - National Accounts: J. M.. Explore Orphazyme A/S's employee directory with LeadIQ.

What industry does Orphazyme A/S belong to?

Orphazyme A/S operates in the Biotechnology Research industry.

What technology does Orphazyme A/S use?

Orphazyme A/S's tech stack includes jQuery MigrateUnderscore.jsWebpackUbuntuAmazon Web ServicesPHPYoast SEOTwitter.

What is Orphazyme A/S's email format?

Orphazyme A/S's email format typically follows the pattern of . Find more Orphazyme A/S email formats with LeadIQ.

How much funding has Orphazyme A/S raised to date?

As of December 2021, Orphazyme A/S has raised $109M in funding. The last funding round occurred on Feb 07, 2020 for $109M.

When was Orphazyme A/S founded?

Orphazyme A/S was founded in 2009.

Insights

Similar companies to Orphazyme A/S

iTeos Therapeutics

Applied Biological Materials

Theradaptive

ANAVEON AG

AlloVir

Palleon Pharmaceuticals

MaaT Pharma

Orphazyme A/S Tech Stack

Media & News

Orphazyme Aps sold assets to Zevra Therapeutics Inc. in the amount of $12.8M on May 1st '22.

Orphazyme Aps went public on Sep 1st '20.

Orphazyme Aps sells assets to KemPharm, Inc. in the amount of $12.8M.

Orphazyme Aps partnered with KemPharm, Inc. on May 15th '22.

Christophe Bourdon left Orphazyme Aps as CEO on Jan 1st '22.

Orphazyme Aps hired Anders Vadsholt as CEO on Apr 1st '22.

Orphazyme Aps launches update to financial outlook for 2021.

Orphazyme A/S's Email Address Formats

Frequently Asked Questions

Where is Orphazyme A/S's headquarters located?

What is Orphazyme A/S's phone number?

What is Orphazyme A/S's stock symbol?

What is Orphazyme A/S's official website and social media links?

What is Orphazyme A/S's SIC code NAICS code?

How many employees does Orphazyme A/S have currently?

What industry does Orphazyme A/S belong to?

What technology does Orphazyme A/S use?

What is Orphazyme A/S's email format?

How much funding has Orphazyme A/S raised to date?

When was Orphazyme A/S founded?

Orphazyme A/S

Company Overview

Media & News

Orphazyme Aps sold assets to Zevra Therapeutics Inc. in the amount of $12.8M on May 1st '22.

Orphazyme Aps went public on Sep 1st '20.

Orphazyme Aps sells assets to KemPharm, Inc. in the amount of $12.8M.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?